Pharmacology & Drug Discovery Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
LATEST RECOMMENDATION
Dean Sheppard, University of California, San Francisco, USA. F1000 Immunology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
9 Recommendations, most recent by
Guy Zimmerman, University of Utah, USA. F1000 Cell Biology
- Confirmation
- Controversial
- Good for Teaching
- Interesting Hypothesis
- New Finding
Past 7 Days
136
New Recommendations
39,984 total
62
New Articles Recommended
19,485 total
Past 30 Days
-
117Articles Classified As Good for Teaching784 total
-
33Articles Classified As Review / Commentary902 total
-
47Articles Classified As Controversial2,106 total
-
131Articles Classified As Technical Advance12,737 total
-
103Articles Classified As Confirmation5,244 total
-
171Articles Classified As Novel Drug Target8,351 total
-
2Articles Classified As Refutation290 total
-
3Articles Classified As Clinical Trial1,058 total
-
1Articles Classified As Changes Clinical Practice2 total
-
162Articles Classified As Interesting Hypothesis7,435 total
-
465Articles Classified As New Finding28,062 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

